TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18975322

Group type: EXPERIMENTAL
Intervention: R788 100 mg
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: R788 150 mg
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189

Group type: COMPARATOR
Intervention: R788 50 mg
Number of subjects: 189
Study: 16021197

Group type: EXPERIMENTAL
Intervention: Argon laser peripheral iridoplasty (ALPI)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Systemic medications (acetazolamide +/- mannitol)
Number of subjects: 77
Study: 14980092

Group type: EXPERIMENTAL
Intervention: Teledermatology consultation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 11351768

Group type: EXPERIMENTAL
Intervention: Aspirin (25 mg b.d.)
Number of subjects: 6602

Group type: EXPERIMENTAL
Intervention: Dipyridamole (400 mg b.d.)
Number of subjects: 6602

Group type: EXPERIMENTAL
Intervention: Combination of aspirin and dipyridamole
Number of subjects: 6602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6602
Study: 9197296

Group type: EXPERIMENTAL
Intervention: Alfentanil by computer-controlled infusion
Number of subjects: 46

Group type: COMPARATOR
Intervention: Amitriptyline (25 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Amitriptyline (25 mg) plus Alfentanil
Number of subjects: 46

Group type: COMPARATOR
Intervention: Midazolam (4 mg)
Number of subjects: 46
Study: 1566090

Group type: EXPERIMENTAL
Intervention: PU gravity-drainage systems
Number of subjects: 56

Group type: COMPARATOR
Intervention: PVC (Redon) drainage systems
Number of subjects: 56
Study: 3916837

Group type: EXPERIMENTAL
Intervention: Ketanserin (60 mg daily for the first month, 120 mg daily for the second and third months)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 15
Study: 31597650

Group type: EXPERIMENTAL
Intervention: Attachment-based compassion therapy (ABCT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Adapted mindfulness-based stress reduction (MBSR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 90
Study: 28520666

Group type: EXPERIMENTAL
Intervention: Anger Self-Management Training (ASMT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Personal Readjustment and Education (PRE)
Number of subjects: 90
Study: 25749495

Group type: COMPARATOR
Intervention: Non-respiratory physiotherapist treatments
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Respiratory physiotherapist treatments
Number of subjects: 93
Study: 22777853

Group type: EXPERIMENTAL
Intervention: Tenodesis of the extensor carpi ulnaris
Number of subjects: 0

Group type: COMPARATOR
Intervention: No tenodesis of the extensor carpi ulnaris (Control)
Number of subjects: 0
Study: 21153660

Group type: EXPERIMENTAL
Intervention: 55% VO₂(max)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 75% VO₂(max)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both exercise intensities (I1 and I2)
Number of subjects: 0
Study: 19015858

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 17383818

Group type: EXPERIMENTAL
Intervention: SRT plus specific cognitive exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: SRT (placebo)
Number of subjects: 50
Study: 12574184

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/d
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10477245

Group type: EXPERIMENTAL
Intervention: Diet high in synthetic triglycerides of stearic acid (18:0) for four weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diet high in synthetic triglycerides of palmitic acid (16:0) for four weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diet high in synthetic triglycerides of myristic acid (14:0) for four weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Baseline diet providing 11 energy (en)% saturated fat
Number of subjects: 18
Study: 8692531

Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette‐Guérin (BCG)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Epirubicin
Number of subjects: 132
Study: 1762975

Group type: EXPERIMENTAL
Intervention: Transparent adherent dressing (TAD) changed every four days
Number of subjects: 98

Group type: COMPARATOR
Intervention: Dry sterile gauze dressing (DSGD) changed daily
Number of subjects: 98
Study: 6754845

Group type: EXPERIMENTAL
Intervention: Pre-exposure immune serum globulin
Number of subjects: 23447

Group type: COMPARATOR
Intervention: Non-immunised group (control)
Number of subjects: 23447
Study: 6323376

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ampicillin/Chloramphenicol
Number of subjects: 25
Study: 29313186

Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy (MST)
Number of subjects: 697

Group type: COMPARATOR
Intervention: Functional Family Therapy (FFT)
Number of subjects: 697
Study: 26461811

Group type: EXPERIMENTAL
Intervention: Large-scale community and school-level interventions promoting handwashing with soap
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 24885844

Group type: EXPERIMENTAL
Intervention: Self-management group intervention (10 hours total, facilitated group workshop sessions)
Number of subjects: 300

Group type: COMPARATOR
Intervention: No-treatment (wait list) control condition
Number of subjects: 300
Study: 22403699

Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 3134

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody (mAb) immunotherapy
Number of subjects: 3134

Group type: COMPARATOR
Intervention: Vaccine subgroup
Number of subjects: 3134

Group type: EXPERIMENTAL
Intervention: Cytokine immunotherapy
Number of subjects: 3134

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3134
Study: 20332358

Group type: EXPERIMENTAL
Intervention: Exenatide 1.25 microg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Exenatide 2.5 microg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Insulin monotherapy
Number of subjects: 8
Study: 18759643

Group type: EXPERIMENTAL
Intervention: Risperidone (RIS)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 232
Study: 15969642

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide/0.5% timolol combination eye drops twice daily
Number of subjects: 544

Group type: COMPARATOR
Intervention: 0.005% latanoprost eye drops once daily
Number of subjects: 544
Study: 14506621

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 16
Study: 10385131

Group type: EXPERIMENTAL
Intervention: Timolol maleate gel forming solution 0.5% (Timoptic‐XE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Timolol hemihydrate 0.5% (Betimol)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (HypoTears)
Number of subjects: 14
Study: 8895240

Group type: EXPERIMENTAL
Intervention: Noradrenaline iontophoresis in untreated skin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Noradrenaline iontophoresis in capsaicin-treated skin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Cuff pressure of 200 mmHg in capsaicin-treated skin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Noradrenaline during arterial occlusion in capsaicin-treated skin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Noradrenaline during arterial occlusion in untreated skin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Reactive hyperaemia after cuff pressure release in capsaicin-treated skin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Reactive hyperaemia after cuff pressure release in untreated skin
Number of subjects: 13
Study: 1476282

Group type: COMPARATOR
Intervention: albumin 4%
Number of subjects: 60

Group type: COMPARATOR
Intervention: dextran 40 3.5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: dextran 60 6%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: hydroxyethylstarch (HES) 200 6%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: modified fluid gelatin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ringer lactate
Number of subjects: 60
Study: 6304203

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg/m2 per day for two weeks)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 31542730

Group type: EXPERIMENTAL
Intervention: Transition team
Number of subjects: 105
Study: 28408059

Group type: EXPERIMENTAL
Intervention: BCAAs + HPHF diet (1.2g/kg protein, 30g fiber, 110g BCAAs daily)
Number of subjects: 72

Group type: COMPARATOR
Intervention: HPHF diet (1.2g/kg protein, 30g fiber)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: BCAAs + HPHF diet
Number of subjects: 72

Group type: COMPARATOR
Intervention: HPHF diet
Number of subjects: 72
Study: 27035404

Group type: EXPERIMENTAL
Intervention: L-methylfolate calcium 15 mg
Number of subjects: 68
Study: 24527996

Group type: EXPERIMENTAL
Intervention: mTBIMVA vignette
Number of subjects: 244

Group type: COMPARATOR
Intervention: mTBIsport vignette
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Personal knowledge of mTBI
Number of subjects: 244
Study: 22404241

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) with levobupivacaine, ketorolac, and epinephrine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal morphine (it‐M) 0.1 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal morphine (it‐M)
Number of subjects: 60
Study: 20537376

Group type: EXPERIMENTAL
Intervention: ART initiated
Number of subjects: 3381

Group type: COMPARATOR
Intervention: No ART
Number of subjects: 3381

Group type: COMPARATOR
Intervention: No ART with CD4 < 200 cells per microL
Number of subjects: 3381

Group type: COMPARATOR
Intervention: No ART with CD4 > 200 cells per microL
Number of subjects: 3381
Study: 17031691

Group type: EXPERIMENTAL
Intervention: L-carnitine (50 mg/kg/day)
Number of subjects: 30
Study: 16198779

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 37

Group type: COMPARATOR
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Pimecrolimus
Number of subjects: 37
Study: 15538055

Group type: EXPERIMENTAL
Intervention: Facilitated PCI with thrombolytic therapy plus glycoprotein IIb/IIIa inhibitor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitated PCI with glycoprotein IIb/IIIa inhibitor alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitated PCI with thrombolytic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitated PCI (general)
Number of subjects: 0
Study: 10365803

Group type: EXPERIMENTAL
Intervention: Ribavirin (800 mg/day) plus leucocytic interferon-alpha (3 mega units thrice weekly)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Interferon-alpha alone (3 mega units thrice weekly)
Number of subjects: 50
Study: 8523983

Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fine-needle capillary biopsy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 0
Study: 1851191

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (6 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no nedocromil sodium)
Number of subjects: 19
Study: 7012996

Group type: EXPERIMENTAL
Intervention: Bacampicillin (800 mg twice a day)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Amoxicillin (500 mg three times a day)
Number of subjects: 77
Study: 31056956

Group type: EXPERIMENTAL
Intervention: Food insecurity status assessment using the 10-item US Household Food Security Scale Module
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Factors associated with food insecurity
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Father's occupation as a farmer
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Mother's occupation as a farmer
Number of subjects: 398
Study: 27903520

Group type: COMPARATOR
Intervention: Low-fat, high-carbohydrate (LFHC) diet (30% of energy fat and 53% of energy carbohydrate)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Very high-fat, low-carbohydrate (VHFLC) diet (73% of energy fat and 10% of energy carbohydrate)
Number of subjects: 46
Study: 26360740

Group type: EXPERIMENTAL
Intervention: Laparoscopic floppy Nissen fundoplication (LNF)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Laparoscopic Toupet fundoplication (LTF)
Number of subjects: 84
Study: 24214585

Group type: EXPERIMENTAL
Intervention: Intravenous pantoprazole (initial dose 40 mg, then 40 mg every 12 hours for 3 days, followed by 40 mg orally)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Intravenous ranitidine (initial dose 50 mg, then every 8 hours for 3 days, followed by 150 mg every 12 hours)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Intravenous pantoprazole
Number of subjects: 89

Group type: COMPARATOR
Intervention: Intravenous ranitidine
Number of subjects: 89
Study: 20631407

Group type: EXPERIMENTAL
Intervention: 750 mg dietary phosphorus diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: lanthanum carbonate 1000 mg three times daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1500 mg dietary phosphorus diet plus placebo
Number of subjects: 16
Study: 20095352

Group type: COMPARATOR
Intervention: Preoperative chemotherapy history (C group, n = 52)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: No preoperative chemotherapy history (N group, n = 55)
Number of subjects: 107
Study: 16441928

Group type: EXPERIMENTAL
Intervention: Olive oil-based lipid emulsion (OO group)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Soybean oil-based lipid emulsion (SO group)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Comparison between OO and SO
Number of subjects: 35
Study: 15319104

Group type: COMPARATOR
Intervention: Neutral dorsiflexion position
Number of subjects: 109

Group type: COMPARATOR
Intervention: Dorsiflexed position
Number of subjects: 109

Group type: COMPARATOR
Intervention: Plantarflexed position
Number of subjects: 109
Study: 10945316

Group type: EXPERIMENTAL
Intervention: Transdermal mecamylamine 6 mg/24 h
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 12
Study: 9396102

Group type: EXPERIMENTAL
Intervention: Letters condition
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Proactive condition
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Hotline use
Number of subjects: 177
Study: 8454793

Group type: EXPERIMENTAL
Intervention: 10,000 standardized quality units (SQ-U) (0.7 microgram Der p I)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 100,000 SQ-U (7 micrograms Der p I)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 300,000 SQ-U (21 micrograms Der p I)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: N/A (control group with no injections)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: N/A (systemic reactions)
Number of subjects: 74
Study: 3783150

Group type: EXPERIMENTAL
Intervention: Vegetarian diet (1,000 kcal per day for six weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed diet (1,000 kcal per day for six weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relative carbohydrate intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ratio of plasma tryptophan to other large neutral amino acids
Number of subjects: 0
Study: 30476065

Group type: EXPERIMENTAL
Intervention: Fit & Strong! Plus (F&S! Plus)
Number of subjects: 413
Study: 30257847

Group type: EXPERIMENTAL
Intervention: Stand-alone pilot/feasibility studies
Number of subjects: 176

Group type: COMPARATOR
Intervention: External pilot/feasibility studies
Number of subjects: 176

Group type: COMPARATOR
Intervention: Internal pilot/feasibility studies
Number of subjects: 176
Study: 27382674

Group type: EXPERIMENTAL
Intervention: Dermatophagoides farina extracts sublingual immunotherapy for 2 years
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (pharmacotherapy)
Number of subjects: 77
Study: 26237978

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: NSES (Neck-skin electrical stimulation)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acupuncture + NSES (Combined treatment)
Number of subjects: 120

Group type: COMPARATOR
Intervention: NSES
Number of subjects: 120
Study: 23912267

Group type: EXPERIMENTAL
Intervention: Alumina-on-alumina ceramic bearing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Alumina-on-highly cross-linked polyethylene bearing
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 21803113

Group type: EXPERIMENTAL
Intervention: Rivastigmine 3 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rivastigmine 0 mg (placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivastigmine 6 mg
Number of subjects: 0
Study: 19803577

Group type: EXPERIMENTAL
Intervention: Family CBT (FCBT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Individual cognitive‐behavioral therapy (ICBT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Family-based education/support/attention control (FESA)
Number of subjects: 53
Study: 16698473

Group type: EXPERIMENTAL
Intervention: CCTI (temporal clear corneal incision)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: CCOI (on-axis clear corneal incision)
Number of subjects: 61

Group type: COMPARATOR
Intervention: CCTI and CCOI
Number of subjects: 61
Study: 15596155

Group type: EXPERIMENTAL
Intervention: Psychosocial interventions based on the modified reattribution model
Number of subjects: 127

Group type: COMPARATOR
Intervention: Nonspecific psychosocial primary care (PPC)
Number of subjects: 127
Study: 11493293

Group type: EXPERIMENTAL
Intervention: Pulsed CO2 laser
Number of subjects: 13

Group type: COMPARATOR
Intervention: Er:YAG laser
Number of subjects: 13
Study: 9404178

Group type: COMPARATOR
Intervention: Caudal epidural block with 0.25% bupivacaine 1 ml.kg‐1 and preservative‐free ketamine 0.5 mg.kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ilioinguinal nerve block with 0.25% bupivacaine 0.5 ml.kg‐1 and infiltration of the wound with 0.25% bupivacaine 0.5 ml.kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ilioinguinal nerve block
Number of subjects: 40
Study: 8558350

Group type: EXPERIMENTAL
Intervention: Complete immediate dentures
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Immediate overdentures on two lower canines without attachments
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Immediate overdentures on two lower canines with Dyna direct magnetic attachments
Number of subjects: 74
Study: 2671424

Group type: EXPERIMENTAL
Intervention: NY‐198
Number of subjects: 258

Group type: COMPARATOR
Intervention: NFLX
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: NY‐198-NY‐198
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: NFLX-NFLX
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: NY‐198-placebo
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: NFLX-placebo
Number of subjects: 258

Group type: COMPARATOR
Intervention: NY‐198 and NFLX
Number of subjects: 258
Study: 1053479

Group type: EXPERIMENTAL
Intervention: Furosemide (loop diuretic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potassium-sparing diuretic added to thiazide or furosemide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretics in diuretic doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Furosemide or increased dose of loop diuretic
Number of subjects: 0
Study: 30676468

Group type: EXPERIMENTAL
Intervention: IC‐ECG guidance (n = 80)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Anatomical landmark guidance (n = 80)
Number of subjects: 160
Study: 27604568

Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 25939111

Group type: EXPERIMENTAL
Intervention: Videotape training (23 minutes)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Six experimental training conditions (including videotape + psychomotor skill training + cognitive rehearsal training)
Number of subjects: 265
Study: 23621525

Group type: EXPERIMENTAL
Intervention: Antireflux metal stent (ARMS)
Number of subjects: 13
Study: 22401279

Group type: EXPERIMENTAL
Intervention: hCG (3000 IU intramuscular injection on day 5 after oestrus)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Saline (intramuscular injection on day 5 after oestrus)
Number of subjects: 27
Study: 20080961

Group type: EXPERIMENTAL
Intervention: Vacuum‐formed retainer in the maxilla and bonded canine‐to‐canine retainer in the mandible (group V‐CTC)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Vacuum‐formed retainer in the maxilla combined with stripping of the 10 proximal surfaces of the lower mandibular anterior teeth (group V‐S)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Prefabricated positioner covering the teeth in the maxilla and mandible (group P)
Number of subjects: 75
Study: 18001713

Group type: EXPERIMENTAL
Intervention: Mucuna pruriens treatment
Number of subjects: 120
Study: 16511633

Group type: EXPERIMENTAL
Intervention: Closed Tracheal Suction System (CTSS) without daily change
Number of subjects: 457

Group type: COMPARATOR
Intervention: Open Tracheal Suction System (OTSS)
Number of subjects: 457
Study: 12555294

Group type: EXPERIMENTAL
Intervention: Intermittent Pringle manoeuvre
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 11127843

Group type: EXPERIMENTAL
Intervention: Methyldopa (long term use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-receptor antagonists (short term use <6 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous dihydralazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine (concurrent with MgSO4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 0
Study: 9257783

Group type: EXPERIMENTAL
Intervention: Short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens from grass and rye pollen (n = 41)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens from grass and rye pollen (n = 22)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 87